Navigation Links
Advanced Instruments Acquires Mart Microbiology B.V.
Date:11/19/2007

NORWOOD, Mass., Nov. 19 /PRNewswire/ -- Advanced Instruments, Inc., of Norwood, Massachusetts, announced today that it has acquired 100% of the shares of Mart Microbiology B.V. of The Netherlands. The terms of the transaction were not disclosed.

Mart Microbiology manufactures and markets the Anoxomat(TM) line of instruments. These systems create custom environments for anaerobic bacteria cultivation, a process which requires oxygen-deprived atmospheres. Typical applications include the diagnosis of post-operative infection in hospitals and clinics, plus bacterial cultivation in food microbiology labs.

Anoxomat provides many advantages over traditional methods of cultivating anaerobes. The system can quickly create a precision anaerobic environment that enables reliable and rapid bacteria cultivation. It uses less lab space than traditional "glove box" cabinets and can provide typical returns on investment in less than one year.

Advanced Instruments has been the U.S. distributor of Anoxomat products for more than 6 years and has placed many systems at leading American medical centers. In addition, Mart products are sold in other global regions through an established factory-trained dealer network.

"Mart Microbiology is a perfect fit for our company," said John Coughlin, President and CEO, Advanced Instruments. "It is the clear market leader in this developing technology and compliments our company's market presence globally. The experience gained as Anoxomat's U.S. distributor gives us a high degree of confidence in making this strategic move," he said.

Advanced Instruments currently operates a facility in The Netherlands and the operations of Mart Microbiology will be integrated into that facility in early 2008.

About Advanced Instruments, Inc.

Founded in 1955, Advanced Instruments, Inc. is the world's largest supplier of freezing-point osmometers used in clinical, pharmaceutical, and biotechnology laboratories. The company is also a leading supplier of analytical instruments and test kits for the food, dairy, and industrial microbiology markets. Based in Norwood, Massachusetts, USA, the privately held company also produces Fiske(R) Associates brand diagnostic instruments and operates Spiral Biotech, Inc., and Delta Instruments as wholly-owned subsidiaries.

Advanced Instruments' products are supported by a worldwide network of direct sales people and independent distributors. Reach Advanced Instruments online at http://www.aicompanies.com or contact us at 800-225-4034 or +1-781-320-9000.


'/>"/>
SOURCE Advanced Instruments, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. Advanced Life Sciences Announces Receipt of Nasdaq Staff Letter
3. Advanced Cell Technology Announces Proposed Financing
4. YM BIOSCIENCES, EUROPEAN PARTNER, ONCOSCIENCE AG, ANNOUNCES INITIATION OF ADVANCED NIMOTUZUMAB TRIALS IN ADULT GLIOMA AND PANCREATIC CANCER
5. Advanced Cell Technologys Dr. Robert Lanza Makes List of 100 Most Inspiring People in the Life-Sciences Industry
6. Advanced Life Sciences to Present at 2007 UBS Global Life Sciences Conference
7. CeloNova BioSciences Announces Worlds First Line of Fully Color-Coded Embolic Particles at CIRSE: Embozene(TM) Color-Advanced Microspheres
8. Edwards Lifesciences Grants UC Irvine $5 Million to Establish the Edwards Lifesciences Center for Advanced Cardiovascular Technology
9. Advanced Bionics Deploys CEVA-TeakLite(TM) DSP Core to Enhance Its Harmony(TM) HiResolution(R) Bionic Ear System
10. NIH Announces Advanced Cell Technologys Single Cell Embryo Biopsy Technique as a Means to Derive Embryonic Stem Cells to be Considered for Federal Funding
11. Cell Therapeutics, Inc. (CTI) Receives SPA Approval from FDA and Launches Gender-Specific Phase III Trial for Advanced Non-Small Cell Lung Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2017)... ... May 23, 2017 , ... ... cells for research and the development of cardiac regeneration therapies. The development ... numbers of cardiomyocytes (hPSC-CMs). Due to varying differentiation efficiencies, further enrichment of ...
(Date:5/23/2017)... ... May 22, 2017 , ... NetDimensions has been ranked as ... Globe™ for Corporate Learning, 2017. , Aragon Research defines Leaders as organizations who ... perform against those strategies. NetDimensions’ ranking as a Leader due to its strengths ...
(Date:5/23/2017)... ... 2017 , ... Vortex Biosciences , provider of circulating tumor cell (CTC) ... cells using Vortex microfluidic technology ” in Nature Precision Oncology on May 8th. ... Carlo and Dr. Matthew Rettig at the University of California, Los Angeles. The publication ...
(Date:5/23/2017)... (PRWEB) , ... May 23, 2017 , ... ... Works as Vice President of Clinical Operations. She brings years of expertise ... Yaupon Therapeutics. From her professional foundation as a licensed occupational therapist, through a ...
Breaking Biology Technology:
(Date:3/29/2017)... March 29, 2017  higi, the health IT company ... North America , today announced a Series ... acquisition of EveryMove. The new investment and acquisition accelerates ... tools to transform population health activities through the collection ... higi collects and secures data today on ...
(Date:3/23/2017)... The report "Gesture Recognition and Touchless Sensing Market by Technology (Touch-based and ... 2022", published by MarketsandMarkets, the market is expected to be worth USD 18.98 ... Continue Reading ... ...      ...
(Date:3/20/2017)... At this year,s CeBIT Chancellor Dr. Angela Merkel visited the ... the DERMALOG stand together with the Japanese Prime Minster Shinzo Abe. ... largest German biometrics company the two government leaders could see the three ... as DERMALOG´s multi-biometrics system.   Continue Reading ... ...
Breaking Biology News(10 mins):